BSE Live
Oct 21, 14:46Prev. Close
2.12
Open Price
2.13
Bid Price (Qty.)
2.13 (274)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Profit & Loss account of Vivanza Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 2.94 | 14.41 | 14.21 | 9.15 | 9.22 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 2.94 | 14.41 | 14.21 | 9.15 | 9.22 | |
Total Operating Revenues | 2.94 | 14.41 | 14.21 | 9.15 | 9.22 | |
Other Income | 0.03 | 0.05 | 0.39 | 0.83 | 0.50 | |
Total Revenue | 2.98 | 14.47 | 14.59 | 9.98 | 9.72 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Purchase Of Stock-In Trade | 2.67 | 13.17 | 12.34 | 10.31 | 8.11 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -0.04 | -0.19 | 0.62 | -1.83 | 0.46 | |
Employee Benefit Expenses | 0.37 | 0.31 | 0.26 | 0.12 | 0.29 | |
Finance Costs | 0.35 | 0.41 | 0.42 | 0.41 | 0.47 | |
Depreciation And Amortisation Expenses | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | |
Other Expenses | 0.31 | 0.32 | 0.27 | 0.50 | 0.24 | |
Total Expenses | 3.67 | 14.04 | 13.91 | 9.51 | 9.57 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -0.69 | 0.43 | 0.69 | 0.46 | 0.15 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | -0.69 | 0.43 | 0.69 | 0.46 | 0.15 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 0.00 | 0.11 | 0.12 | 0.00 | 0.05 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 0.00 | 0.11 | 0.12 | 0.00 | 0.05 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | -0.70 | 0.32 | 0.57 | 0.46 | 0.10 | |
Profit/Loss From Continuing Operations | -0.70 | 0.32 | 0.57 | 0.46 | 0.10 | |
Profit/Loss For The Period | -0.70 | 0.32 | 0.57 | 0.46 | 0.10 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | -0.17 | 0.08 | 1.42 | 1.16 | 0.25 | |
Diluted EPS (Rs.) | -0.17 | 0.08 | 1.42 | 1.16 | 0.25 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
13.05.2025
Vivanza Bio Standalone March 2025 Net Sales at Rs 0.17 crore, down 92.62% Y-o-Y
13.05.2025
Vivanza Bio Consolidated March 2025 Net Sales at Rs 0.48 crore, down 89.08% Y-o-Y
01.02.2025
Vivanza Bio Consolidated December 2024 Net Sales at Rs 1.50 crore, down 77.13% Y-o-Y
01.02.2025
Vivanza Bio Standalone December 2024 Net Sales at Rs 0.76 crore, down 77.36% Y-o-Y
13.05.2025
Vivanza Bio Standalone March 2025 Net Sales at Rs 0.17 crore, down 92.62% Y-o-Y
13.05.2025
Vivanza Bio Consolidated March 2025 Net Sales at Rs 0.48 crore, down 89.08% Y-o-Y
01.02.2025
Vivanza Bio Consolidated December 2024 Net Sales at Rs 1.50 crore, down 77.13% Y-o-Y
01.02.2025
Vivanza Bio Standalone December 2024 Net Sales at Rs 0.76 crore, down 77.36% Y-o-Y